Research and experimental development on natural sciences and engineering
PROPHYLAXIA SIGNS AS
Revenue 2024
NOK 3.9m
Operating profit
NOK 922,000
Equity
NOK −3.1m
Incorporated
2010
Share capital
NOK 150,000
Roles
Daglig lederIvar Gulla
Regnskapsfører
Styrets lederBjørn-Vegard Løvik
StyremedlemIvar Gulla
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| SIGNS SAS | 49.0% | 73500.000000 | 2025 |
| ALSCO AQUA AS | 40.8% | 61200.000000 | 2025 |
| AKVAPROSJEKTER AS | 10.2% | 15300.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.